ABSTRACT The microRNA-126 (miR-126) is a miR-NA expressed in highly vascularized tissues, and it is believed to play a role in angiogenesis by repressing sprouty-related EVH1 domain containing 1 (Spred1). In the current study, we determined the expression pattern of chicken miR-126 (gga-miR-126) and predicted and validated its target genes. The quantitative reverse-transcription (qRT) PCR analysis showed that miR-126 was expressed in various chicken tissues with the highest level in lung. In liver, the expression level of miR-126 increased from 0 to 7 wk of age. The expression of miR-126 in primary chicken hepatocytes decreased with culturing. A miR-126 binding site was predicted in the 3′ UTR (untranslated region) of chicken Spred1. Dual-luciferase reporter assays indicated that miR-126 could bind to the predicted site to repress the expression of Spred1. These data validate Spred1 as a target gene of chicken miR-126. These results will help further understand the function and regulation of miR-126 and Spred1 in chickens.
INTRODUCTION
MicroRNA (miRNA) are a class of small noncoding RNA about 22 nt in length that regulate gene expression by interacting with the 3′ untranslated region (UTR) of target mRNA (Bartel, 2004) . The miR-126 is an intragenic miRNA transcribed from the intron 7 of the epidermal growth factor-like domain 7 (EGFL7) gene (Fish et al., 2008; Meister and Schmidt, 2010) . The miR-126 is expressed in highly vascularized tissues such as liver (Landgraf et al., 2007; Han et al., 2012; Novellino et al., 2012) , heart (Long et al., 2012) , and lung (Guan et al., 2012) , and in hematopoietic cells (Grabher et al., 2011) and endothelial cells (Wang et al., 2008) .
The miR-126 plays important roles in many biological processes. It enhances serine/threonine kinase and mitogen-activated protein kinase (MAPK) signaling (Chen and Zhou, 2011) by suppressing the p85β protein. It mediates ischemia-induced angiogenesis by activating vascular endothelial growth factor (Vegf) signaling, a mechanism that was previously attributed to EGFL7 (Kuhnert et al., 2008; van Solingen et al., 2009; Nicoli et al., 2010) . Two transcription factors, E26 avian leukemia oncogene (Ets)-1 and Ets-2, which are involved in cell development, death, and tumorigenesis, induce the expression of miR-126 and regulate vascular development via miR-126 (Harris et al., 2010) . Though miR-126 promotes angiogenesis, it inhibits erythropoiesis. It negatively regulates erythropoiesis by repressing the expression of protein tyrosine phosphatase, nonreceptor type 9 (PTPN9), which is required for growth and expansion of erythroid cells (Huang et al., 2011) . Knockdown of miR-126 increases the expression of its target myeloblastosis oncogene (c-myb) to enhance erythropoiesis in zebrafish (Grabher et al., 2011) . The miR-126 also regulates inflammation by repressing the expression of vascular cell adhesion molecule (VCAM-1), an adhesion molecule that mediates leukocyte adherence to endothelial cells (Harris et al., 2008) .
The miR-126 may play an important role in the liver. The miR-126 is the most downregulated miRNA when primary rat hepatocytes are cultured (Bolleyn et al., 2011) . The miR-126 is downregulated in hepatocellular carcinoma (HCC; Han et al., 2012; Wong et al., 2008) . Expression of miR-126 is also repressed in lung cancer tissues (Guan et al., 2012) and colon cancer tissues (Guo et al., 2008) .
Because the expression level of miR-126 in poultry liver is different from that in other species (Meister and Schmidt, 2010) , we chose liver to further study its exMicroRNA-126 expression is decreased in cultured primary chicken hepatocytes and targets the sprouty-related EVH1 domain containing 1 mRNA pression profile. Based on its expression profiles in liver tissue of different status, we hypothesized that miR-126 might play a role in development of the poultry liver. In this study, target genes of the chicken miR-126 (ggamiR-126) were predicted using computational methods. One of the predicted target genes, Spred1, is known to inhibit Ras-MAPK signaling in cell growth and differentiation (Wakioka et al., 2001 ). We used a series of experiments to confirm that Spred1 is a true target of miR-126.
MATERIALS AND METHODS

Computational Prediction of miR-126 Target Genes
The 3′ UTR sequences of Gallus gallus were downloaded from the 3′ UTR database (http://utrdb.ba.itb. cnr.it/; Mignone et al., 2005) . The miRNA target prediction software "miRanda v 1.0b" (Enright et al., 2003) was used to predict the binding sites between miR-126 and the 3′ UTR of mRNA using the default parameters. The "TargetScan" principle was also applied in the prediction procedures: the target site should match to the seed region of miRNA (nucleotides 2-7), the 8th nucleotide of miRNA should also be a match or the target nucleotide corresponding to the first nucleotide of miRNA should be an A (Lewis et al., 2003 (Lewis et al., , 2005 . The target site in 3′ UTR of Spred1 mRNA was further analyzed for a Basic Local Alignment Search Tool (BLAST) search in GenBank (http://www.ncbi.nlm. nih.gov), and its homology to other species was analyzed using DNAMAN.
RNA Isolation and Real-Time Quantitative Reverse-Transcription PCR
Total RNA of various tissues from 4-wk-old and livers from 0-, 1-, 2-, 3-, 4-, 5-, 6-, and 7-wk-old Arbor Acres commercial chickens was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA). The RNA concentrations and quality were determined by NanoDrop ND2000 spectrophotometry (Thermo Scientific, Wilmington, DE) and formaldehyde-agarose gel electrophoresis. The expression of miR-126 in tissues was detected by real-time quantitative reverse-transcription (qRT)-PCR according to the protocol of TaqMan MicroRNA Assay (Applied Biosystems, Foster City, CA; Chen et al., 2005) . The RT reaction and the PCR were performed using TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems) and TaqMan Universal Master Mix II, no UNG in an Applied Biosystems 7500 Thermocycler (Applied Biosystems). All reactions were run in duplicate. The threshold cycle (C T ) was defined as the fractional cycle number at which the fluorescence passes the fixed threshold. The expression levels of miRNA were measured in terms of C T value and normalized to 18S rRNA (Applied Biosystems) using 2 −ΔΔCT (Livak and Schmittgen, 2001 ). The expression of target gene was detected according to the protocol of PrimeScript RT reagent kit and SYBR Premix Ex Taq (Takara, Dalian, China). β-Actin was used as an internal control. The sequences of primers for this study are listed in Table 1 .
Isolation and Culture of Primary Chicken Hepatocytes
Chicken hepatocytes were isolated using an improved 2-step collagenase method (Douaire et al., 1993) . In brief, 4-wk-old chickens were fasted 12 h (h) before being anaesthetized by intraperitoneal injection of natrium thiopenthal (50 mg/kg) and anticoagulated by intraperitoneal injection of heparin (1,750 U/kg). Livers were first perfused with 250 mL of buffer A (5 mmol/L EDTA, 10 mmol/L of HEPES, 137 mmol/L of NaC1, 3 mmol/L of KCl, 3 mmol/L of Na 2 HPO 4 , pH 7.5) for 10 min and then with 250 mL of buffer B (buffer A without EDTA) for 10 min. Then livers were perfused with 5 mL of buffer C (buffer B containing 0.6 mg/mL of CaCl 2 and 0.4 mg/mL of collagenase type IV) and digested at 37°C for 20 min. Livers were excised and incubated in 5 mL of buffer C at 37°C for 20 min. Digestion was stopped by adding William's E medium (Gibco, Grand Island, NY) supplemented with 5% chicken serum and 2 mg/mL of BSA. After filtering through 200-, 75-, and 30-μm filters, cells were incubated with red blood cell lysis buffer and washed with wash buffer 
(William's E medium containing 100 U/mL of penicillin-streptomycin and 2 mg/mL of BSA) to eliminate cell fragments and erythrocytes. The cell viability was verified by trypan blue exclusion test. All procedures involving animals were approved by Changshu Institute of Technology Intramural Animal Use and Care Committee.
Isolated hepatocytes were cultured at a density of 1.3 × 10 6 cells/mL in William's E medium supplemented with 5% chicken serum, 100 U/mL of penicillin-streptomycin, 10 μg/mL of insulin, and 30 mmol/L of NaCl at 37°C with 5% CO 2 in a humidified incubator. After 2 d, the RNA of cells was isolated and the expression of miR-126 and Spred1 was detected by real-time qRT-PCR.
Construction of Plasmids
The sequence containing precursor of miR-126 was PCR amplified from chicken genomic DNA. The PCR product was cloned into the pcDNA3.1 (+) vector (Invitrogen) using the HindIII and XhoI restriction sites to construct miR-126 overexpression vector pcDNA3.1/ miR-126. A negative control vector pcDNA3,1/NCmiRNA was constructed by inserting the sequence containing precursor of miR-133 (had no predicted target site in the 3′ UTR of Spred1) into pcDNA3.1. The 3′ UTR fragment of Spred1 containing predicted miR-126 binding site was amplified from chicken genomic DNA and inserted between SacI and HindIII sites within the pMIR-REPORT vector (Ambion, Carlsbad, CA) to construct a pMIR-Spred1 reporter vector. Binding site mutated vector pMIR-mutSpred1 was generated from pMIR-Spred1 using overlap-extension PCR ( Figure  1A ). The vector pMIR-mmuSpred1 containing 3′ UTR fragment of mouse Spred1 was constructed as well. All constructed vectors were verified by sequencing.
Cell Culture and Transfection
The Chinese hamster ovary (CHO) cells, C2C12 myoblasts, and chicken cell line DF-1 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 2 mM l-glutamine, 1 mM sodium pyruvate, 100 U/mL of penicillin-streptomycin, and 10% fetal bovine serum (Gibco) at 37°C with 5% CO 2 in a humidified incubator. For miRNA overexpression assay, cells were seeded in 6-well plates for 24 h and transfected with pcDNA3.1/miR-126 using X-tremeGENE 9 DNA Transfection Reagent (Roche, Mannheim, Germany) according to the manufacturer's protocol. In brief, 3 μL of X-tremeGENE 9 DNA Transfection Reagent was added into 87 μL of serum-free Dulbecco's modified Eagle's medium, 10 μL of pcDNA3.1/miR-126 (100 ng/ μL) was then added and incubated at room temperature for 15 min, and then 100 μL of the complex was added to each well. The control used was pcDNA3.1. After 48 h, RNA of cells was isolated and used to quantify the expression levels of miR-126 and Spred1 by real-time qRT-PCR following the protocols described previously.
Luciferase Reporter Assay
The CHO cells were seeded in 24-well plates for 24 h before transfection. Fifty nanograms of pMIR-Spred1 (Firefly luciferase), pMIR-mutSpred1, or pMIR-mmuSpred1, 350 ng of pcDNA3.1/miR-126, and 1 ng of internal control pRL-CMV (Renilla luciferase) were mixed and then cotransfected into cells using X-tremeGENE 9 DNA Transfection Reagent (Roche) following the manufacturer's instructions. The pcDNA3.1 and pcD-NA3.1/NC-miRNA were used as controls. Cells were harvested and lysed in passive lysis buffer 48 h posttransfection. Luciferase activities were measured using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI). After 15 min of lysis at room temperature, 10 μL of cell lysate was transferred to 50 μL of Luciferase Assay Reagent II (LAR II), and the Firefly luciferase activity was measured in a Modulus single tube luminometer (Turner BioSystems, Sunnyvale, CA). Then, 50 μL of Stop & Glo Reagent was added and the Renilla luciferase activity was measured. Firefly luciferase activity was normalized to Renilla luciferase activity. 
Statistical Analysis
All data are presented as means ± SEM of at least 3 independent experiments performed in duplicate or triplicate. Statistical analysis was performed using the Student's t-test, one-way ANOVA, or linear correlation test. A P-value < 0.05 was considered statistically significant.
RESULTS
Target Prediction of miR-126
To predict the target genes of miR-126, the chicken 3′ UTR data were analyzed by the computational algorithm "miRanda" with "TargetScan" principle. Of 11,891 chicken genes, 54 genes were predicted to be the targets of miR-126. Most of the predicted targets seemed to have good binding interactions with miR-126. The predicted targets and the complementarity between miR-126 and the predicted targets were listed in Supplemental Table 1 (available online at http:// ps.fass.org/). Among the 54 predicted targets, only 5 have conserved target sites across species. They are Spred1, TELO2, PLK2, CRK, and TRAF7. A 3′ UTR site of Spred1 was predicted to interact stably with miR-126 and the nucleotides 1-7 of miR-126 were completely complementary to the sequence at this 3′ UTR site ( Figure 1A) . The Spred1 3′ UTR of other species were also analyzed using BLAST and DNAMAN, and they had more than 80% identity with each other. The chicken sequence is more than 90% identical to the mouse, human, rat, or rabbit Spred1 3′ UTR at the predicted miR-126 binding site. The seed region of the target site is completely identical to those of other species ( Figure 1B ).
Expression Pattern of miR-126 and Spred1
The expression of miR-126 in 12 various tissues from 4-wk-old chickens and in livers from chickens of 8 different developmental stages was detected using realtime qRT-PCR. The expression of Spred1 in livers from chickens of 8 different developmental stages was also detected using real-time qRT-PCR. The miR-126 was detected in all 12 tissues with very different expression levels. It was expressed at high levels in lung and heart, low levels in adipose tissue, spleen, and muscular stomach, and very low levels in the other tissues such as liver (Figure 2 ). During liver development from 0 to 7 wk, the expression level of miR-126 had a trend of increasing ( Figure 3A) , but the expression level of Spred1 showed no significant changes ( Figure 3B ).
miR-126 Is Downregulated in Cultured Primary Chicken Hepatocytes
Primary chicken hepatocytes were isolated and cultured using an improved 2-step collagenase method (Douaire et al., 1993) . By trypan blue exclusion test, the cell viability was analyzed to be more than 95%. After isolation and cultivation, the hepatocytes were collected and the expression of miR-126 and Spred1 mRNA was detected by real-time qRT-PCR. The expression level of miR-126 was significantly lower in isolated hepatocytes than in liver; its expression was even lower after 2 d of cultivation ( Figure 4A ). Some other miRNA were also downregulated in the hepatocytes with cultivation (data not shown); however, the decreases were not as significant as that in miR-126. The expression level of Spred1 mRNA was not different between newly isolated hepatocytes and liver, and did not change with cultivation ( Figure 4B ). 
miR-126 Directly Targets the 3′ UTR of Spred1
To investigate whether the miR-126 overexpression vector could increase the expression level of miR-126, the construct pcDNA3.1/miR-126 was transfected into CHO cells and C2C12 cells and then the RNA was isolated. The expression level of miR-126 was quantified by real-time qRT-PCR. Compared with control samples transfected with pcDNA3.1, the expression level of miR-126 in pcDNA3.1/miR-126 transfected cells increased significantly ( Figure 5A and Supplemental Figure 1 ; available online at http://ps.fass.org/). Because the fold change of overexpression was more in CHO than in C2C12 cells, the CHO cells were chosen for further studies.
To determine whether the predicted target site of miR-126 in the 3′ UTR of Spred1 was true, the pMIRSpred1 reporter vector was cotransfected into CHO cells with miR-126 overexpression vector pcDNA3.1/ miR-126 or control vectors pcDNA3.1 or pcDNA3.1/ NC-miRNA. The pRL-CMV was also cotransfected to normalize the luciferase activity of pMIR-Spred1. The relative luciferase activity of pMIR-Spred1 decreased with the presence of pcDNA3.1/miR-126 compared with the controls (Figure 5B) . In other words, overexpressed miR-126 downregulated the expression of pMIR-Spred1. Thus, miR-126 was validated to directly target the Spred1 3′ UTR. To further verify the target site, the binding site-mutated plasmid pMIR-mutSpred1 was cotransfected to CHO cells with pcDNA3.1/miR-126 and control pcDNA3.1, and homologous 3′ UTR fragment of mouse Spred1 was cloned to construct 3′ UTR reporter vector pMIR-mmuSpred1, and this vector was also cotransfected along with miR-126 overexpression or control vectors. As a result, the relative luciferase activity of pMIR-mutSpred1 was not significantly different between cells overexpressing miR-126 and the control ( Figure 5B ), indicating that the suppression of the relative luciferase activity by miR-126 The expression levels of Spred1 in livers at 8 stages from 0 to 7 wk were analyzed by real-time qRT-PCR and normalized to β-actin. Experiments were repeated 2 times with 3 chickens at every stage. Data are means ± SEM and analyzed by ANOVA. *P < 0.05; **P < 0.01. Other significance data in (A): **1 to 7 wk, 3 to 7 wk, 4 to 7 wk; *1 to 6 wk.
was relieved by mutation of the target site. The relative luciferase activity of pMIR-mmuSpred1 also decreased in the presence of pcDNA3.1/miR-126 compared with the controls (Supplemental Figure 2 ; available online at http://ps.fass.org/). Thus, miR-126 directly targeted the 3′ UTR of mouse Spred1 as well. These data together verified that miR-126 directly interacted with the predicted target site in the 3′ UTR of Spred1 and that Spred1 was a target gene of miR-126.
miR-126 Did Not Regulate Chicken Spred1 at the mRNA Level
To investigate whether miR-126 regulated chicken Spred1 at the mRNA level, the pcDNA3.1/miR-126 or control vector pcDNA3.1 was transfected into chicken cell line DF-1 cells and then the expression of miR- The expression levels of sprouty-related EVH1 domain containing 1 (Spred1) in liver and in hepatocytes before and after culture was analyzed by real-time qRT-PCR and normalized to β-actin. 1: liver, 2: hepatocytes isolated from liver, 3: hepatocytes after 2 d of culture. Experiments were repeated 2 times with three 4-wk-old chickens. Data are means ± SEM and analyzed by ANOVA. **P < 0.01; ***P < 0.001. 
DISCUSSION
In this study, 54 genes were predicted as the target genes of miR-126 among 11,891 genes in the 3′ UTR database using the "miRanda" with "TargetScan" principle. One of the predicted target genes of miR-126 is Spred1, which encodes a sprouty-related receptor tyrosine kinase binding protein and has a conserved target site across species. Similar to sprouty, Spred proteins are located on plasma membrane and can inhibit Ras-MAPK signaling induced by growth factors such as FGF to regulate cell growth, proliferation, and differentiation (Wakioka et al., 2001; Sivak et al., 2005; Mason et al., 2006) . The Spred1 is expressed in several types of tissues. In hematopoietic cells, it negatively regulates hematopoiesis through inhibiting interleukin-3 induced MAPK signaling (Nonami et al., 2004) ; in myoblast C2C12, it promotes myogenesis by repressing MAPK activity (Wakioka et al., 2001) . Its role in liver is not clear. Because the complementarity between Spred1 and miR-126 is high (Figure 1) , we studied the characteristics of Spred1 in poultry liver.
The expression profile of miR-126 in 12 chicken tissues showed that miR-126 was expressed in highly vascularized tissues such as lung, heart, and spleen. This finding is consistent with the expression pattern of miR-126 in other species (Guan et al., 2012; Han et al., 2012; Long et al., 2012) . The miR-126 is expressed in the lung at a significantly higher level than in other tissues, indicating that it may play a particularly important role in the lung. Previous reports depict that it is downregulated in lung carcinoma versus normal lung cells (Yanaihara et al., 2006; Boeri et al., 2011) , implying miR-126 has very important roles in maintaining lung in a normal state. So the high expression level of miR-126 may be important to the normal state of the lung. The expression level of miR-126 in poultry liver is very low. This is different from that in other species, where miR-126 is abundant in the liver (Meister and Schmidt, 2010) . The increasing expression of miR-126 from 0 to 7 wk of age suggests that miR-126 may play more important roles in late developmental stages than in early stages.
Culture of primary chicken hepatocytes is based on a classic 2-step collagenase method with modifications. Our modifications help increase the yield of healthy hepatocytes. The viability of the hepatocytes we obtained was more than 95%, which was higher than those in previous reports (Fraslin et al., 1992; Douaire et al., 1993) . In a previous report, miR-126 is identified as the most downregulated miRNA in primary rat hepatocytes after 2 and 7 d of cultivation using microarray and real-time qRT-PCR. The fold change is 13 after 7 d of cultivation by microarray, but after 2 d of cultivation the fold change is less. Using real-time qRT-PCR, the expression level of miR-126 is downregulated about 70% after 2 d of cultivation (Bolleyn et al., 2011) . In this study, we found that the expression level of miR-126 in chicken hepatocytes was downregulated to 2.7% after 2 d of cultivation. The downregulation of miR-126 during hepatocyte culturing may be due to dedifferentiation of the hepatocytes and reentry to the cell cycle (Elaut et al., 2006) .
Using dual-luciferase reporter assays, chicken Spred1 was validated to be the target gene of miR-126, which was further confirmed by the site mutation analysis. Our identification of chicken Spred1 as a chicken miR-126 target is consistent with earlier reports (Kuhnert et al., 2008; Wang et al., 2008) . The Spred1 may regulate the Ras-MAPK signaling in liver. In HCC cells, Spred1 is dysregulated, and it inhibits HCC cell proliferation by reducing MAPK activity (Yoshida et al., 2006) . Silibinin could inhibit HCC cell proliferation through inhibition of MAPK activity, which is indirectly caused by upregulation of Spred1 and other factors (Momeny et al., 2008) . In mouse preadipocytes, calcium treatment suppresses lipid accumulation by promotion of MAPK signaling (Sun et al., 2012a,b) . In mouse hepatocytes, carnosic acid reduces lipid accumulation through activation of MAPK . So chicken Spred1 may also regulate lipid metabolism by repressing Ras-MAPK signaling in hepatocytes. We also analyzed another previously predicted target gene lipoprotein lipase , but the result showed that miR-126 did not regulate the expression of this gene (data not shown). Shown in previous reports, miR-126 targets Spred1 to regulate angiogenesis and vascular integrity in endothelial cells and mast cell proliferation in bone marrow, and miR-126 regulates the expression of Spred1 by repressing the expression of its mRNA (Wang et al., 2008; Ishizaki et al., 2011) . In our study, the expression pattern of Spred1 was not inversely correlated with that of miR-126, and the mRNA level of Spred1 in DF-1 cells was not regulated by miR-126, implying that the expression of Spred1 in chicken tissues may be regulated by factors in addition to miR-126.
In conclusion, miR-126 is expressed in various chicken tissues and is upregulated in livers during development and downregulated in primary hepatocytes after cultivation. The Spred1 is one of the target genes for miR-126.
